Supply Chain

AI’s role in pharma operations and process is growing. But does it have the power to transform the industry?

We asked the field’s greatest minds: “What improvements do we need to see in cell and gene supply chains?”

How one CDMO navigated the pandemic and came out on top of industry trends

The US drug supply chain is not immune to counterfeits – but there’s a law for that. Here’s how it has been used so far.

The world wasn’t ready for COVID-19. But if we learn the right lessons, next time next time we’ll do better.

COVID-19 has taught us that unexpected events can cause significant supply chain disruption, so pharma must be prepared.

Cytiva is transforming in the wake of COVID-19 – but what lessons can the wider biopharma industry take forward?

The COVID-19 pandemic exposed weaknesses in pharma supply chains. It’s time to address these.

Driven by the success of COVID-19 vaccines, mRNA products are expanding drug developers’ pipelines.

Overcoming supply chain woes will require digital intervention.